Diabetic neuropathy and heart failure: role of neuropeptides (Q37914972)

25 August 2017

1 reference

title

Diabetic neuropathy and heart failure: role of neuropeptides (English)

1 reference

25 August 2017

0 references

1 reference

Asma Ejaz

1

1 reference

PubMed ID

21831336

25 August 2017

Frank W LoGerfo

series ordinal

2

1 reference

PubMed ID

21831336

25 August 2017

Leena Pradhan

series ordinal

3

1 reference

25 August 2017

10 August 2011

1 reference

Expert Reviews in Molecular Medicine

25 August 2017

1 reference

25 August 2017

13

1 reference

25 August 2017

e26

1 reference

Cardioprotection by ischemic postconditioning is lost in isolated perfused heart from diabetic rats: Involvement of transient receptor potential vanilloid 1, calcitonin gene-related peptide and substance P.

25 August 2017

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Capsaicin induces a depletion of calcitonin gene-related peptide (CGRP)-immunoreactive nerves in the cardiovascular system of the guinea pig and rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

TRPV1 gene knockout impairs postischemic recovery in isolated perfused heart in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Gene expression of pro-inflammatory cytokines and neuropeptides in diabetic wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Neurohumoral changes in patients with left ventricular dysfunction following acute myocardial infarction and the effect of nitrate therapy: a randomized, double-blind, placebo-controlled long-term study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

The role of nitric oxide in the failing heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Nerve fibre studies in skin biopsies in peripheral neuropathies. I. Immunohistochemical analysis of neuropeptides in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

'Sensing' autoimmunity in type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Tachykinins: receptor to effector

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Spatial differentiation of the intestinal epithelium: analysis of enteroendocrine cells containing immunoreactive serotonin, secretin, and substance P in normal and transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Experimental immunohistochemical studies on the localization and distribution of substance P in cat primary sensory neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Up-regulation of substance P and NMDA receptor mRNA in dorsal horn and preganglionic sympathetic neurons during adjuvant-induced noxious stimulation in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Different regulation of atrial ANP release through neuropeptide Y2 and Y4 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Role of atrial natriuretic peptides and neuropeptide Y in blood pressure regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Effects of neuropeptide Y on collateral development in a swine model of chronic myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Neuropeptide Y (NPY) potentiates phenylephrine-induced mitogen-activated protein kinase activation in primary cardiomyocytes via NPY Y5 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Expression of neuropeptide Y and its receptors Y1 and Y2 in the rat heart and its supplying autonomic and spinal sensory ganglia in experimentally induced diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Neuropeptide Y regulates intracellular calcium through different signalling pathways linked to a Y(1)-receptor in rat mesenteric small arteries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Diabetic autonomic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Pathomechanism of diabetic neuropathy: background of the pathogenesis-oriented therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Nitrosative stress, uric Acid, and peripheral nerve function in early type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Can VEGF reverse diabetic neuropathy in human subjects?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Specific fiber deficits in sensorimotor diabetic polyneuropathy correspond to cytotoxicity against neuroblastoma cells of sera from patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Sympathetic neurogenic Ca2+ signalling in rat arteries: ATP, noradrenaline and neuropeptide Y.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Neuropeptide Y: an endogenous inhibitor of norepinephrine-stimulated melatonin secretion in the rat pineal gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Chronic type II diabetes mellitus leads to changes in neuropeptide Y receptor expression and distribution in human myocardial tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Diminished contractile responses to neuropeptide Y of arteries from diabetic rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Direct and indirect modulation of neuropeptide Y gene expression in response to hypoglycemia in rat arcuate nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Heterogenous changes in neuropeptide Y, norepinephrine and epinephrine concentrations in the hearts of diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Interactions of multiple signaling pathways in neuropeptide Y-mediated bimodal vascular smooth muscle cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Ghrelin directly interacts with neuropeptide-Y-containing neurons in the rat arcuate nucleus: Ca2+ signaling via protein kinase A and N-type channel-dependent mechanisms and cross-talk with leptin and orexin

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Neuropeptide Y: the universal soldier

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Therapeutic potential of neuropeptide Y (NPY) receptor ligands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Neuropeptide Y: a new mediator linking sympathetic nerves, blood vessels and immune system?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Altered cerebrospinal fluid neuropeptide Y and peptide YY immunoreactivity in anorexia and bulimia nervosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Neuropeptide Y distribution in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Y-receptor subtypes--how many more?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

PKC-1 regulates secretion of neuropeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Effect of hyperglycemia and neuropeptides on interleukin-8 expression and angiogenesis in dermal microvascular endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Inflammation and neuropeptides: the connection in diabetic wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Deletion of neuropeptide Y (NPY) 2 receptor in mice results in blockage of NPY-induced angiogenesis and delayed wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Neuropeptide Y induces cardiomyocyte hypertrophy via calcineurin signaling in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Acrylamide-induced autonomic neuropathy of rat mesenteric vessels: histological and pharmacological studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Cardiac autonomic neuropathy in diabetes: a clinical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Absence of hypertension despite chronic marked elevations in plasma norepinephrine in conscious dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Important role of endogenous norepinephrine and epinephrine in the development of in vivo pressure-overload cardiac hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Diabetic heart muscle disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

The impact of Cardiovascular Autonomic Neuropathy in diabetes: is it associated with left ventricular dysfunction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Autonomic testing: common techniques and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Cardiovascular autonomic neuropathy due to diabetes mellitus: clinical manifestations, consequences, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Cardiovascular autonomic neuropathy: diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Review article: Diabetes mellitus and heart failure--an overview of epidemiology and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Diabetic neuropathy--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Foot muscle energy reserves in diabetic patients without and with clinical peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Diabetic peripheral neuropathy: effects of age, duration of diabetes, glycemic control, and vascular factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Subcutaneous administration of brain natriuretic peptide in experimental heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Diabetic painful and insensate neuropathy: pathogenesis and potential treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

A prospective study in search of an optimal B-natriuretic peptide level to screen patients for cardiac dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Nerve growth factor and diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Meta-analysis of B-type natriuretic peptide's ability to identify stress induced myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Clinical applicability of B-type natriuretic peptide in patients with suspected heart failure in primary care in Spain: the PANAMA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Diabetic cardiomyopathy: mechanisms, diagnosis and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

A functional role for endogenous atrial natriuretic peptide in a canine model of early left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Dual inhibition of angiotensin converting enzyme and neutral endopeptidase by omapatrilat in rat in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Diabetes and the platelet: toward new therapeutic paradigms for diabetic atherothrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

The peroxisome proliferator-activated receptor-gamma agonist pioglitazone represses inflammation in a peroxisome proliferator-activated receptor-alpha-dependent manner in vitro and in vivo in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Effect of atrial natriuretic peptide on left ventricular remodelling in patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Chronic heart failure in the United States: a manifestation of coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Influence of diabetes mellitus on heart failure risk and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Preoperative cardiac evaluation does not improve or predict perioperative or late survival in asymptomatic diabetic patients undergoing elective infrainguinal arterial reconstruction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Autocrine and paracrine effects of atrial natriuretic peptide gene transfer on vascular smooth muscle and endothelial cellular growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Hyperglycemia and the pathobiology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Impact of natriuretic peptide clearance receptor (NPR3) gene variants on blood pressure in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Neurohormonal profile of patients with heart failure and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Prognostic role of B-type natriuretic peptide levels in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Impaired angiotensin II regulation of renal C-type natriuretic peptide mRNA expression in experimental diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Receptors for atrial natriuretic peptide are decreased in the kidney of rats with streptozotocin-induced diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Cardiovascular autonomic function assessed by autonomic function tests and serum autonomic neuropeptides in Egyptian children and adolescents with rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Atrial natriuretic peptide prevents diabetes-induced endothelial dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Atrial natriuretic factor inhibits vasopressin-stimulated osmotic water permeability in rat inner medullary collecting duct

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Ten years of natriuretic peptide research: a new dawn for their diagnostic and therapeutic use?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

The genetic contribution of the natriuretic peptide system to cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Regulation of guanylyl cyclase/natriuretic peptide receptor-A gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

C-type natriuretic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Nitroglycerin protects small intestine from ischemia-reperfusion injury via NO-cGMP pathway and upregulation of alpha-CGRP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Autonomic neuropathy is associated with impaired pancreatic polypeptide and neuropeptide Y responses to insulin-induced hypoglycaemia in Type I diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Neuropeptide Y and CGRP concentrations in the rat tail artery: Effects of age and two types of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Intramuscular transfer of naked calcitonin gene-related peptide gene prevents autoimmune diabetes induced by multiple low-dose streptozotocin in C57BL mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Diabetes mellitus and heart failure: basic mechanisms, clinical features, and therapeutic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Heart failure and diabetes mellitus: epidemiology and management of an alarming association

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Prevalence and clinical implications of American Diabetes Association-defined diabetes and other categories of glucose dysregulation in older adults: the health, aging and body composition study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

The molecular pharmacology of CGRP and related peptide receptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Characterization of CGRP1 and CGRP2 receptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

Atrial natriuretic peptide in type 2 diabetes mellitus: response to a physiological mixed meal and relationship to renal function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

7 January 2021

Early potential impairment of renal sensory nerves in streptozotocin-induced diabetic rats: role of neurokinin receptors

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

7 January 2021

Neuropeptide Y infusion decreases plasma renin activity in postmyocardial infarction rats

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

7 January 2021

Substance P is associated with heart enlargement and apoptosis in murine dilated cardiomyopathy induced by Taenia crassiceps infection

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

7 January 2021

Endogenous substance P modulates human cardiovascular regulation at rest and during orthostatic load

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

7 January 2021

Recognizing and treating diabetic autonomic neuropathy.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

7 January 2021

Characterisation of calcitonin gene-related peptide receptors in rat atrium and vas deferens: evidence for a [Cys(Et)(2, 7)]hCGRP-preferring receptor

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

7 January 2021

https://api.crossref.org/works/10.1017%2FS1462399411001979

1 reference

7 January 2021

Effects of natriuretic peptides on load and myocardial function in normal and heart failure dogs

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

7 January 2021

Letter: Clinical evaluation of a newly designed contoured toothbrush

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

7 January 2021

Congestive heart failure: involvement of perivascular peptides reflecting activity in sympathetic, parasympathetic and afferent fibres

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

7 January 2021

Metabolic and vascular factors in the pathogenesis of diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

7 January 2021

Anti-inflammatory activity of amylin and CGRP in different experimental models of inflammation

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

7 January 2021

Modulation of contractile function through neuropeptide Y receptors during development of cardiomyocyte hypertrophy

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

7 January 2021

Increased plasma level of substance P in patients with severe congestive heart failure treated with ACE inhibitors

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

7 January 2021

Selective attenuation of neuropeptide-Y-mediated contractile responses in blood vessels from patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

7 January 2021

Diabetic cardiovascular autonomic neuropathy: prognosis, diagnosis and treatment.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

7 January 2021

Serum levels of substance P are decreased in patients with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

7 January 2021

Vascular inflammation in proximal diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

7 January 2021

Distribution of calcitonin-gene-related peptide, neuropeptide-Y, vasoactive intestinal polypeptide, cholecystokinin-8, substance P and islet peptides in the pancreas of normal and diabetic rats

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

7 January 2021

Neuropeptide Y prevents agonist-stimulated increases in contractility

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

7 January 2021

Acute hyperglycaemia causes elevation in plasma atrial natriuretic peptide concentrations in Type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

7 January 2021

Left ventricular dysfunction in normotensive Type 1 diabetic patients: the impact of autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

7 January 2021

Adrenoreceptor-mediated effect of neuropeptide Y decreases cardiac inotropic responses

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

7 January 2021

Intracellular signaling leads to the hypertrophic effect of neuropeptide Y

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

7 January 2021

Immunohistochemical measurements of nerves and neuropeptides in diabetic skin: relationship to tests of neurological function

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

7 January 2021

Plasma neuropeptide Y (NPY) and galanin before and during exercise in type 1 diabetic patients with autonomic dysfunction

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

7 January 2021

ANP and bradycardic reflexes in hypertensive rats: influence of cardiac hypertrophy

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

7 January 2021

A deficiency of gastric interstitial cells of Cajal accompanied by decreased expression of neuronal nitric oxide synthase and substance P in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

7 January 2021

https://api.crossref.org/works/10.1017%2FS1462399411001979

1 reference

7 January 2021

Dilatory responses to acetylcholine, calcitonin gene-related peptide and substance P in the congestive heart failure rat

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

7 January 2021

Implication of Substance P in myocardial contractile function during ischemia in rats

1 reference

https://api.crossref.org/works/10.1017%2FS1462399411001979

7 January 2021

10.1017/S1462399411001979

Identifiers

DOI

1 reference

25 August 2017

1 reference

PubMed ID

21831336